BPG is committed to discovery and dissemination of knowledge
Featured Articles
Splenic stiffness measurement to predict decompensation in compensated advanced chronic liver disease
Browse: 112   Download: 344   Issue Date: 2026-09-17
From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B
Browse: 86   Download: 269   Issue Date: 2026-09-17
Hepatocellular carcinoma with obstructive jaundice: Biliary drainage and multimodal therapy
Browse: 97   Download: 250   Issue Date: 2026-09-17
Molecular characteristics and carcinogenic mechanisms of aflatoxin B1-associated hepatocellular carcinoma: Recent advances
Browse: 81   Download: 255   Issue Date: 2026-09-17
Predicting pancreatic fistula risk after splenectomy in cirrhotic splenomegaly: Surgical anatomy and implications
Browse: 83   Download: 240   Issue Date: 2026-09-17
Letter to the Editor: Filling the gaps in non-invasive assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease
Browse: 118   Download: 371   Issue Date: 2026-08-18
Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease and fibrosis in recently diagnosed type 2 diabetes
Browse: 98   Download: 523   Issue Date: 2026-08-18
Effect of hepatic venous pressure gradient in different hepatic venous branches on assessing portal hypertension in cirrhotic patients
Browse: 95   Download: 547   Issue Date: 2026-08-18
Metabolic dysfunction-associated steatotic liver disease and the consequence of extra-hepatic malignancy
Browse: 111   Download: 274   Issue Date: 2026-08-18
Peribiliary and colonic crypt glands in primary sclerosing cholangitis and inflammatory bowel disease pathogenesis: New research perspectives
Browse: 82   Download: 335   Issue Date: 2026-08-18
Poria in Fuling Zexie decoction for treating metabolic dysfunction-associated steatotic liver disease: Underlying mechanisms and key bioactive substances
Browse: 141   Download: 717   Issue Date: 2026-07-24
Activated cGAS-STING signaling promotes malignancy in metabolic dysfunction-associated fatty liver disease via mitochondrial DNA and immune cell dysfunction
Browse: 126   Download: 649   Issue Date: 2026-07-24
Saroglitazar ameliorates alcoholic liver disease and is associated with enhanced ethanol metabolism
Browse: 143   Download: 650   Issue Date: 2026-07-24
Computed tomography-based correction of the body mass index improves malnutrition detection in patients with cirrhosis and ascites
Browse: 117   Download: 690   Issue Date: 2026-07-24
Translational potential of the interleukin-6/interleukin-10 ratio for immune monitoring after radiofrequency ablation
Browse: 119   Download: 545   Issue Date: 2026-07-24
Tyrosine kinase inhibitors after progression on atezolizumab-bevacizumab in advanced hepatocellular carcinoma: A systematic review and meta-analysis
Browse: 178   Download: 749   Issue Date: 2026-06-26
Methionine depletion inhibits hepatocellular carcinoma by inducing ferroptosis and suppressing epithelial-mesenchymal transition through the ARNT2/UBE2Z pathway
Browse: 164   Download: 598   Issue Date: 2026-06-26
LECT2/Tie1/Src signaling regulates the oxidative stress response in endothelial cells and liver ischemia-reperfusion injury
Browse: 158   Download: 766   Issue Date: 2026-06-26
Emerging treatment options for metabolic dysfunction-associated steatotic liver disease and its related liver diseases
Browse: 198   Download: 503   Issue Date: 2026-06-26
Metabolic links between metabolic dysfunction-associated steatotic liver disease and primary biliary cholangitis
Browse: 148   Download: 608   Issue Date: 2026-06-26
Write to the Help Desk